Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free BIAFW Stock Alerts

bioAffinity Technologies (BIAFW) Competitors

bioAffinity Technologies logo
$0.13 -0.07 (-33.84%)
As of 03:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

BIAFW vs. ALVOW, APLMW, ARAV, BIVIW, and CDIOW

Should you buy bioAffinity Technologies stock or one of its competitors? bioAffinity Technologies's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does bioAffinity Technologies compare to Alvotech?

bioAffinity Technologies (NASDAQ:BIAFW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 1.89 beat Alvotech's score of 1.87 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company Overall Sentiment
bioAffinity Technologies Very Positive
Alvotech Very Positive

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
Alvotech$491.95MN/AN/AN/AN/A

Summary

bioAffinity Technologies and Alvotech tied by winning 1 of the 2 factors compared between the two stocks.

How does bioAffinity Technologies compare to Apollomics?

Apollomics (NASDAQ:APLMW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

In the previous week, Apollomics and Apollomics both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 equaled bioAffinity Technologies'average media sentiment score.

Company Overall Sentiment
Apollomics Very Positive
bioAffinity Technologies Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
bioAffinity Technologies$5.85MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

Summary

Apollomics beats bioAffinity Technologies on 1 of the 1 factors compared between the two stocks.

How does bioAffinity Technologies compare to Aravive?

bioAffinity Technologies (NASDAQ:BIAFW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Aravive N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, bioAffinity Technologies had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Aravive. bioAffinity Technologies' average media sentiment score of 1.89 beat Aravive's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company Overall Sentiment
bioAffinity Technologies Very Positive
Aravive Neutral

Summary

bioAffinity Technologies beats Aravive on 3 of the 5 factors compared between the two stocks.

How does bioAffinity Technologies compare to BioVie?

BioVie (NASDAQ:BIVIW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
bioAffinity Technologies$5.85MN/AN/AN/AN/A

In the previous week, BioVie had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 2 mentions for BioVie and 1 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 1.89 beat BioVie's score of 0.63 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Positive
bioAffinity Technologies Very Positive

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

Summary

bioAffinity Technologies beats BioVie on 2 of the 3 factors compared between the two stocks.

How does bioAffinity Technologies compare to Cardio Diagnostics?

bioAffinity Technologies (NASDAQ:BIAFW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 1.89 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
bioAffinity Technologies Very Positive
Cardio Diagnostics Very Positive

Summary

bioAffinity Technologies beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

Get bioAffinity Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIAFW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIAFW vs. The Competition

Export
MetricbioAffinity TechnologiesBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.89B$7.21B$15.01B
Dividend YieldN/A3.65%2.57%12.21%
P/E RatioN/A14.11272.8425.31
Price / SalesN/A1,434.33701.69107.35
Price / CashN/A108.9477.7151.48
Price / BookN/A15.1710.376.18
Net IncomeN/A-$22.78M$3.49B$357.96M
7 Day Performance-78.06%-2.55%-2.20%-1.61%
1 Month PerformanceN/A0.29%-0.38%-3.62%
1 Year PerformanceN/A39.29%19.16%5.95%

bioAffinity Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIAFW
bioAffinity Technologies
N/A$0.13
-33.8%		N/A+182.9%$0.00$5.85MN/A10
ALVOW
Alvotech
N/A$0.30
flat		N/A-65.9%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
flat		N/A-21.1%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIVIW
BioVie
N/A$0.36
+8.5%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BIAFW) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel